Authors
Loading...
This review highlights anticoagulant therapy differences in atrial fibrillation patients with renal dysfunction, indicating key safety and efficacy considerations.
Кобалава et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: